Oystein Fluge

Bergen, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Erratum to: "A simplified frailty score predicts outcome in curatively treated older patients with classical Hodgkin lymphoma".

Erratum to: "A simplified frailty score predicts outcome in curatively treated older patients with classical Hodgkin lymphoma".

Journal: Haematologica

Published: August 01, 2026

A targeted circulating tumor DNA landscape of copy number aberrations in large B-cell lymphomas.

A targeted circulating tumor DNA landscape of copy number aberrations in large B-cell lymphomas.

Journal: Leukemia

Published: November 13, 2025

Correction: SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis.

Correction: SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis.

Journal: Journal of translational medicine

Published: August 14, 2025

Expert perspectives on Myalgic encephalomyelitis/chronic fatigue syndrome - Insights from the 3rd International Conference of the Charité Fatigue Center.

Expert perspectives on Myalgic encephalomyelitis/chronic fatigue syndrome - Insights from the 3rd International Conference of the Charité Fatigue Center.

Journal: Autoimmunity reviews

Published: August 12, 2025

Charting the circulating proteome in ME/CFS using cross-system profiling to uncover mechanistic insights.

Charting the circulating proteome in ME/CFS using cross-system profiling to uncover mechanistic insights.

Journal: Cell reports. Medicine

Published: May 28, 2025

Response to Comment on: "A simplified frailty score predicts outcome in curatively treated older patients with classical Hodgkin lymphoma".

Response to Comment on: "A simplified frailty score predicts outcome in curatively treated older patients with classical Hodgkin lymphoma".

Journal: Haematologica

Published: May 25, 2025

Killer cell immunoglobulin-like receptor (KIR) alleles suggested to be associated with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

Killer cell immunoglobulin-like receptor (KIR) alleles suggested to be associated with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

Journal: Brain, behavior, and immunity

Published: May 14, 2025

SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis.

SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis.

Journal: Journal of translational medicine

Published: April 10, 2025

Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome-a clinical pilot study.

Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome-a clinical pilot study.

Journal: Frontiers in medicine

Published: April 07, 2025

A simplified frailty score predicts outcome in curatively treated older patients with classical Hodgkin lymphoma.

A simplified frailty score predicts outcome in curatively treated older patients with classical Hodgkin lymphoma.

Journal: Haematologica

Published: February 03, 2025

Biomarker-adapted treatment in high-risk large B-cell lymphoma.

Biomarker-adapted treatment in high-risk large B-cell lymphoma.

Journal: HemaSphere

Published: November 29, 2024

Altered effort and deconditioning are not valid explanations of myalgic encephalomyelitis/chronic fatigue syndrome.

Altered effort and deconditioning are not valid explanations of myalgic encephalomyelitis/chronic fatigue syndrome.

Journal: Nature communications

Published: February 21, 2024

Showing 1-12 of 62

Last Updated: 09/26/2026